PETS PetMed Express, Inc.

0.9244USD+2.56%Mkt Cap: 20.55M USDP/E: —

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, …

Institutional holders20 on file

Key Statistics

Company
Market Cap20.55M USD
Enterprise Value8.00M USD
Revenue (TTM)160.26M USD
Gross Profit50.22M USD
Net Income (TTM)-57.29M USD
Revenue/Share7.62 USD
Last Price0.9244 USD
Fiscal Year EndMar 2026
MR QuarterSep 2026
Employees189
CountryUS
SectorHealthcare
IndustryPharmaceutical Retailers
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-30.81
PEG2.32
EV/EBITDA-0.45
EV/Revenue0.05
P/S0.13
P/B1.16
EPS (TTM)-1.29 USD
EPS (Forward)-0.03 USD
52W Range
0.85002% of range4.100
52W High4.100 USD
52W Low0.8500 USD
Profitability
Gross Margin28.05%
Oper. Margin-16.91%
EBITDA Margin-11.20%
Profit Margin-32.00%
ROE-197.95%
ROA-70.56%
ROIC-389.12%
ROCE-107.74%
Growth
Revenue Growth-19.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-28.39M USD
CapEx (TTM)4.62M USD
FCF Margin-8.34%
FCF Yield-65.03%
Net Debt-11.13M USD
Net Debt/EBITDA0.62
Net Debt/FCF—
Balance Sheet
Debt/Equity0.02
Current Ratio0.60
Quick Ratio0.30
Book Value/Sh0.80 USD
Cash/Share0.54 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield5.79%
Payout Ratio0.00%
Ex-Div DateAug 11, 2023
Pay DateAug 18, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.22.23M
Float13.42M
Insiders17.31%
Institutions35.50%
Short Interest
Short Ratio7.8d
Short % Float4.98%
Short % Out.3.75%
Shares Short829.53K
Short (prev mo.)691.52K
Technical
SMA 501.332 (-30.6%)
SMA 2001.994 (-53.6%)
Beta0.83
S&P 52W Chg12.08%
Avg Vol (30d)123.67K
Avg Vol (10d)175.91K
Technical Indicators
RSI (14)24.4
MACD-0.1080
MACD Signal-0.0893
MACD Hist.-0.0187
BB Upper1.383 USD
BB Middle1.115 USD
BB Lower0.8468 USD
BB Width48.08%
ATR (14)0.0642 USD
Vol Ratio (20d)1.02x

About PetMed Express (NASDAQ: PETS)

›

PetMed Express (NASDAQ: PETS) is listed on Nasdaq, where its shares trade in USD. It belongs to the Pharmaceutical Retailers industry, part of the Healthcare sector, and reports about 189 employees.

The shares were at 0.9244 USD on 19 November 2026, down 63.2% over 52 weeks. Its 52-week range is 0.8500 USD to 4.100 USD: the price is 77.5% below the high and 8.8% above the low.

Its market capitalisation is 20.55M USD.

PetMed Express reports return on equity of -197.9%, an operating margin of -16.9% and revenue down 19.4% year over year.

It holds more cash than debt, a net cash position of 11.13M USD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.